K. Takeuchi

Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey

M. Saruta, N. Ohmiya, S. Terai, 2023, Journal of Gastroenterology.

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

L. Peyrin-Biroulet, W. Reinisch, S. Danese, 2022, Advances in Therapy.

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)

M. Saruta, Jun Kato, N. Ohmiya, 2022, Journal of Gastroenterology.

Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.

M. Dubinsky, S. Vermeire, Xiang Gao, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Drug-induced entero-colitis due to interleukin-17 inhibitor use; capsule endoscopic findings and pathological characteristics: A case report

Kiichiro Yoza, Y. Shimoyama, Keita Saito, 2023, World journal of gastroenterology.